PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Acerus Pharmaceuticals Corporation (ASP.TO)

Equity · Currency in CAD · Last updated Dec 9, 2023
SummaryFinancials

Company Info

ISINCA00444G4051
CUSIP00444G405
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapCA$2.77M
EPS-CA$4.41
Revenue (TTM)CA$3.04M
Gross Profit (TTM)CA$1.00M
EBITDA (TTM)-CA$25.32M
Year RangeCA$0.28 - CA$1.29
Target PriceCA$0.38
Short %0.03%
Short Ratio0.14

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of CA$10,000 in Acerus Pharmaceuticals Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ASP.TO

Acerus Pharmaceuticals Corporation

Return


PeriodReturnBenchmark
Year-To-DateN/A19.92%
1 monthN/A5.06%
6 monthsN/A7.11%
1 yearN/A16.17%
5 years (annualized)N/A11.84%
10 years (annualized)N/A9.85%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20230.00%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Acerus Pharmaceuticals Corporation (ASP.TO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ASP.TO
Acerus Pharmaceuticals Corporation
N/A
^GSPC
S&P 500
1.25

Sharpe Ratio


Rolling 12-month Sharpe Ratio
ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)

Dividend History


Acerus Pharmaceuticals Corporation doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Acerus Pharmaceuticals Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Acerus Pharmaceuticals Corporation was 99.97%, occurring on Jan 10, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.97%Apr 16, 20122694Jan 10, 2023
-91.53%Nov 25, 20093Feb 10, 201018Jan 18, 201121
-90.22%Jan 27, 20113Feb 2, 20113Jul 19, 20116
-48.89%Jul 20, 201120Aug 18, 20113Aug 23, 201123
-20%Oct 3, 20113Oct 5, 20113Oct 11, 20116

Volatility Chart

The current Acerus Pharmaceuticals Corporation volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


ASP.TO (Acerus Pharmaceuticals Corporation)
Benchmark (^GSPC)